Introducing the Briya AIRE Population Agent

Every clinical study starts with a study population. But identifying the patients who actually meet that definition requires researchers to translate each inclusion and exclusion criterion into the right variables, filters, and dataset-specific logic. They must also account for missing data, differences in how clinical concepts are recorded, and whether the resulting cohort truly reflects […]
King’s College Hospital NHS Foundation Trust Joins Briya’s Global Data Network

Briya is building a global research network designed to make healthcare data usable for research across institutions, populations, and geographies. Through a federated infrastructure, healthcare organizations can make data available for approved research while maintaining institutional control, with Briya AIRE providing the AI research layer that helps researchers turn complex clinical data and research questions […]
How to Analyze BRFSS Data Faster with Briya AIRE

An Interview with Prof. Jordan Weiss, NYU Grossman School of Medicine The Behavioral Risk Factor Surveillance System (BRFSS) is a CDC survey conducted annually across all 50 U.S. states and territories, tracking chronic disease, health behaviors, healthcare access, and mental health. It is one of the largest ongoing public health surveys in the country, with […]
The Importance of Shortening Time to Medical Data

It takes 8 to 12 months to gain access to the right medical data. In today’s fast-paced world, the timely availability of medical data is crucial for improving patient outcomes and advancing healthcare research. Delays in accessing real-world data can hinder the effectiveness of treatment plans, slow down the development of new therapies, and impede […]
The Rise of Real-World Evidence: Transforming Healthcare Through Patient Data

The healthcare landscape is being reshaped by the increasing adoption of real-world data (RWD) and real-world evidence (RWE). These emerging disciplines have the potential to revolutionize medical research, drug development, and clinical decision-making by harnessing insights from diverse patient data sources beyond traditional clinical trials. Understanding RWD Sources RWD encompasses a wide array of health-related […]